New & Used Pump IV

Market Value Calculator
 
Manf. Year From
Manf. Year Until
Please Note: Search results for this device do not include the following devices, please select the relevant device if it is of interest to you: Infusion Pump,Ambulatory Infusion Pump,Syringe Pump
 
 
 
 
Item Details
Seller details
Item Price (USD)
Year manufactured

Quick Look

 
Device: Pump IV
Manufacturer: Baxter
Model: PCA II
Premium User
Location: United States, Washington
Rating: 89%
129
This Seller accepts SafeTrade as a payment method
-

Quick Look

 
Device: Pump IV
Manufacturer: Abbott Laboratories
Model: LIFECARE 4100 PCA PLUS II
Premium User
Location: United States, Washington
Rating: 89%
555
This Seller accepts SafeTrade as a payment method
-

Quick Look

 
Device: Pump IV
Manufacturer: Hospira
Model: GemStar
Location: United States, Colorado
1,200
This Seller accepts SafeTrade as a payment method
-

Quick Look

 
Device: Pump IV
Manufacturer: Baxter
Model: PCA II
Location: United States, Texas
425
-

Quick Look

 
Device: Pump IV
Manufacturer: Baxter
Model: PCA II
Location: United States, Florida
100
-

Quick Look

 
Device: Infusion Pump
Manufacturer: Baxter
Model: PCA II
Location: United States, Mississippi
100
-

Quick Look

 
Device: Pump IV
Manufacturer: Smiths Medical
Model: CADD-PCA 5800
Location: United States, North Carolina
250
-

Quick Look

 
Device: Pump IV
Manufacturer: Baxter
Model: AP II Pump
Location: United States, Texas
175
-

Quick Look

 
Device: Pump IV
Manufacturer: Hospira
Model: GemStar
Location: Switzerland, Aargau
Negotiable
-

Quick Look

 
Device: Pump IV
Manufacturer: Alaris Medical
Model: IVAC PCAM
Location: Switzerland, Aargau
Negotiable
-

Quick Look

 
Device: Pump IV
Manufacturer: Baxter
Model: PCA II
Location: United States, New York
Negotiable
-
Page: 1 2 3 4 5
The model & manufacturer of the marked items have changed due to an acquisition between companies, and are also known as:
Current Manufacturer / Model Name Alternative Manufacturer / Model Name
Hospira / LIFECARE 4100 PCA PLUS II Abbott Laboratories / LIFECARE 4100 PCA PLUS II

Pump IV may also be referred to as :

Syringe Pump | Infusion Pump, Patient-Controlled Analgesic | PCA Pump | Patient-Controlled Analgesia Unit | Pain Control Syringe Pump | Pain Control Infusion Pump | Intrathecal Analgesia Unit | Infusion Pump, Demand Analgesia | Epidural Analgesia Unit | Analgesia Unit, Intravenous | Patient-Controlled Analgesic Pump
 

Tips for buying Pump IV

  1. The dose button on the IV pumps should be easily accessible and located on the bolus cord or pump. The patient should easily activate the dose button, and a recessed button or a double-activation requirement should prevent accidental activation. The PCA pump should acknowledge the request with an audible tone, a tactile response, or a visual display.
  2. IV Pumps (Pain Control Syringe Pumps) should be able to log up to 200 events including: error codes, alarms, programmed settings, and dose delivery; the data should be retained for at least 1 year. The pain control syringe pump should be able to display dose, concentration, lockout interval, rate, patient requests, and alarm conditions.
  3. Pain control syringe pumps should be designed to allow clinicians to limit access to the reservoir and controls with a lockbox, combination box, or digital code. Patient-controlled analgesic pumps should allow control of continuous (basal) rate, bolus volume, and time between boluses; the IV pump should be capable of delivery continuously from 0.1 to 99.9 ml/hr.
  4. At least a 12-hour therapy should be supported by the dose delivery system, reservoir, and syringe. For home epidural analgesia unit use, longer operating times are preferable.
  5. PCA pump systems that run entirely off of battery power should have batteries that can last for several days at nominal dose rates.
  6. Line-powered PCA pumps should be able to charge independent of the main power switch. Epidural analgesia units should automatically switch to battery operation if line power fails, and run for at least 4 hours at the maximum dose rate.
  7. Antisiphon valves should accompany intravenous analgesia unit pumps using glass syringes to prevent free-flow in case the syringe breaks.
  8. Audible alarms or indicators should alert patients and staff to conditions such as low or depleted battery, occlusion, near end of infusion.
  9. Occlusion alarm should be sound at >=6 psi. If complete occlusion occurs, the patient-controlled analgesic pump should alarm within three dose activations at every dose-volume setting.
  10. Facilities should consider the ease of transport before purchasing. To facilitate transportation of epidural analgesia units, many suppliers offer specialized bags or pouches.
  11. For most patient-controlled analgesic pump models, free flow protection depends on the use of tubing with an integral pressure activated valve, to connect the pump reservoir to the patient catheter. This valve should allow fluid to flow to the patient only when enough positive pressure is generated by the pump to open the valve.
  12. The key issue of assessment for free-flow protection should be to determine if a tubing set is protected rather than whether a particular patient-controlled analgesic pump model is acceptable.
  13. Facilities need to make sure they do not stock extension sets without a pressure-activated valve in clinical locations where PCA pumps are used.
  14. Some pain control syringe pumps allow the use of larger reservoirs, which may require less frequent reservoir changes.
  15. Some manufacturers of intravenous analgesia units offer prefilled reservoirs, which are usually more expensive than reservoirs filled by the pharmacy, but can be useful in small pharmacies with limited staff, and may also help avoid human errors and accidents associated with filling and labeling reservoirs.
Read more valuable tips on the Medical Equipment Buying Guide by MedWOW >>